US equity futures were steady in subdued trading as traders assessed the outlook for economic growth and interest rates. The dollar advanced |
|
Markets Snapshot | | Market data as of 06:20 am EST. | View or Create your Watchlist | | Market data may be delayed depending on provider agreements. | | |
Five things you need to know | |
|
The year’s wildest trades | |
Investors are ending 2024 by giving thanks to Donald Trump's election victory and the advance of AI. In Bloomberg's annual rundown of which trades flourished and which ones flopped in the past year, investors who kept it simple, by sticking to US Treasury bills or tech stocks, proved smart. Those who bet on Trump prevailing in November's election also had reason to celebrate, with crypto-backers and dollar-fans among the winners. Red-hot US stocks and crypto sparked furious risk-taking, making Exchange-Traded Funds the go-to investment for day traders. It almost didn't pay to think too hard. Leveraged trades briefly blew up in August, while hedge funds with complex strategies took hits. Wagering on whether and when proposed mergers and acquisitions will close also did poorly. Emerging markets again underperformed the US stock market, although Argentina did well for once. Perhaps the wildest rally was found in a niche market in Madrid, where a 2,900% gain was witnessed in the span of seconds. The beneficiary was a bond which investors had given up on amid a series of bank mergers — Simon Kennedy | |
|
Rumble shares surged as much as 55% in US premarket trading on Monday following a $775 million investment from stablecoin issuer Tether. Rumble plans to use some of the proceeds to solidify its balance sheet, according to a statement. Novo Nordisk shares rise as much as 10%, clawing back some of Friday’s 21% plunge after the Danish drugmaker’s experimental obesity shot CagriSema failed to meet its own bar for success. — Kit Rees | |
|
Trump has hired another critic of the US Treasury’s recent managing of the nation’s debt to his incoming administration.
The latest sign-up is Stephen Miran, who, subject to being confirmed by the Senate, will chair Trump’s Council of Economic Advisers.
Miran was a senior economic policy adviser at the Treasury Department during Trump’s first term and is now a fellow at the New York-based Manhattan Institute.
In July, he co-authored a paper with economist Nouriel Roubini which alleged the Treasury had manipulated the issuance of US securities in a way that lowered real borrowing costs across the economy.
Treasury Secretary Janet Yellen declared there was “no such strategy.”
Scott Bessent, Trump's choice to replace Yellen, previously advocated increasing the average maturity of debt issuance.
As bond traders already fret about what the Federal Reserve will do in 2025, another key question is how much will Miran and Bessent stick to their views once in office, at a time when the government will have more debt to sell. — Skylar Woodhouse | |
Word from Wall Street | Goldman Sachs economists "remain confident in our forecasts that rate cuts will continue well into 2025 in all major economies." | Sarah Dong Economist, Goldman Sachs | | |
|
|
|
Enjoying Markets Daily? You might also like: | - Breaking News Alerts for the biggest stories from around the world, delivered to your inbox as they happen
- Odd Lots for Joe Weisenthal and Tracy Alloway’s daily newsletter on the newest market crazes
- The Everything Risk for Ed Harrison’s weekly take on what could upend markets
- Money Stuff for Bloomberg Opinion’s Matt Levine’s newsletter on all things Wall Street and finance
- Points of Return for Bloomberg Opinion’s John Authers’ daily dive into markets
Bloomberg.com subscribers have exclusive access to all of our premium newsletters. | |
|
Like getting this newsletter? Subscribe to Bloomberg.com for unlimited access to trusted, data-driven journalism and subscriber-only insights. Before it’s here, it’s on the Bloomberg Terminal. Find out more about how the Terminal delivers information and analysis that financial professionals can’t find anywhere else. Learn more. Want to sponsor this newsletter? Get in touch here. | | You received this message because you are subscribed to Bloomberg's Markets Daily newsletter. If a friend forwarded you this message, sign up here to get it in your inbox. | | |